Mitochondrial Function After Ketamine
This study is not yet recruiting. It focuses on depression and currently lists study information in Israel.
Key information made simple
This study is looking at learn about the role of mitochondria in response to S-ketamine for people with depression. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
Your next step
The official record suggests in-person participation through a clinic, with sites including Sheba Medical Center in Ramat Gan. Participation appears to center on assessments, scans, or samples rather than trying a new treatment. Common reasons not to take part include pregnancy or breastfeeding. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Sheba Medical Center
- Sponsor type
- Hospital / academic medical center
- Main activity
- observational follow-up
- Intervention
- Not available
- Source
- Official registry link
Want help reviewing this study?
Key study information
- Official title
- Mitochondrial Function After Ketamine
- Condition
- Depression
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- Sheba Medical Center
- Location / country
- Israel
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07399756
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Israel.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Mitochondrial Function After Ketamine
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07399756
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Mitochondrial Function After Ketamine?
This study is exploring observational follow-up for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Sheba Medical Center. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve observational follow-up, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
